British Business Investments is a commercial subsidiary of the British Business Bank that increases the supply and diversity of finance for UK smaller businesses through delivery partners.
Portfolio
5
companies
1nhaler
1nhaler develops a sustainable cardboard dry powder inhaler for medication delivery.
Archangels
Archangels is a business angel syndicate investing in early stage Scottish companies.
Isomer Capital
Isomer Capital invests in European technology companies and venture capital funds.
Algbra
Algbra provides sustainable and values-focused digital finance for unbanked and minority communities.
BrainWaveBank
BrainWaveBank develops a digital platform for remote monitoring of neurological and psychiatric conditions.
Judith Hartley
CEO
Judith brings financial and investment sector governance experience from her former role leading British Business Investments. She currently holds non-executive positions at Northstar Ventures UK, NEL Fund Managers Limited, and the Port of Tyne.
LinkedInThe investment round was led by Archangels with participation from Dr Yusuf Hamied, British Business Investments, and seed investors.
"Our DPI has the potential to become the simplest, most convenient single-dose, disposable inhaler on the market, revolutionising the delivery of critical drugs, without the cost and environmental impact of existing devices."
The Edinburgh based syndicate secured the capital via the Regional Angels Programme.
"The co-investment agreement from British Business Investments means that, in a challenging global market, Archangels will have access to significant levels of aligned co-investment capital. This additional funding will allow us to support current and future portfolio companies to grow their businesses and provide returns for both our investors and the broader Scottish economy. We are in advanced discussions with a number of exciting new companies, and we anticipate seeing these deals coming to fruition over the coming months."
The new co-investment fund is backed by British Business Investments alongside global institutions.
"Together with our partner VC funds we continuously monitor the most promising portfolio companies that have rapidly growing revenues and address a market opportunity that could enable a company to become a world class leader. Isomer Capital Opportunities will typically invest in companies that have been in the Isomer portfolio for more than 8 quarters and demonstrate a strong fully-formed management team with a shared vision of building a global company."
The funding round was backed by SFC Capital, British Business Investments, and New World Group to support financial inclusion.
"We are the first Fintech to take a fully values-based approach to serving communities with a truly systemic approach to financial inclusion. Moreover, we are committed to engaging, educating and empowering minorities to close the wealth and social gaps that exist. There are 1.3 billion addressable people on the planet who remain unbanked. If we want to emerge from the Covid-19 pandemic to a better version of our world, we cannot do that without ensuring that everyone can participate in today’s financial system and therefore be included in modern society."
Par Equity led the Series A round to support technology development and commercial expansion.
"We are delighted to continue working with Par Equity who have been very supportive of our company and our vision. This investment will enable us to continue to develop and commercialise our cutting-edge technology that addresses a major unmet need in the development of novel therapies that can significantly reduce costs of care and improve patient outcomes for millions of people worldwide."
.png)
